Browse Category

NASDAQ:XRAY 27 December 2025 - 6 February 2026

ALGN stock jumps again as Align Technology rides Invisalign earnings beat and fresh analyst targets

ALGN stock jumps again as Align Technology rides Invisalign earnings beat and fresh analyst targets

Align Technology shares rose about 4% to $182.70 by midday Friday, following a strong earnings report and record clear-aligner shipments. The company posted Q4 revenue of $1.05 billion and non-GAAP earnings of $3.29 per share, with 676,900 cases shipped. Align forecast Q1 revenue between $1.01 billion and $1.03 billion. The stock jumped 11% in the previous session.
Dentsply Sirona stock holds $11.5 in early premarket as dividend date passes and earnings come into view

Dentsply Sirona stock holds $11.5 in early premarket as dividend date passes and earnings come into view

Dentsply Sirona shares were unchanged at $11.52 in early premarket trading Monday after closing up 2.7% in the previous session. The stock went ex-dividend Dec. 26 for a $0.16 payout due Jan. 9. About 5.5 million shares traded hands Tuesday, with a 52-week range of $9.71 to $19.64. The company’s next earnings report is expected in late February.
Dentsply Sirona Stock (NASDAQ: XRAY) Update: Analysts’ “Reduce” Consensus, Dividend Timeline, and Key Catalysts Before Monday’s Open

Dentsply Sirona Stock (NASDAQ: XRAY) Update: Analysts’ “Reduce” Consensus, Dividend Timeline, and Key Catalysts Before Monday’s Open

Dentsply Sirona shares closed Friday at $11.52, up 2.7%, with 5.5 million shares traded before U.S. markets shut for the weekend. Wall Street sentiment remains cautious, as 15 analysts tracked by MarketBeat hold a consensus “Reduce” rating and a $15.15 average price target. TipRanks shows a “Hold” consensus with targets clustered in the low-to-mid teens. The company’s $0.16 per share quarterly dividend is payable Jan. 9.
28 December 2025
DENTSPLY SIRONA Stock (NASDAQ: XRAY) Weekend Update: Analysts Hold a “Reduce” View as Year-End Trading Winds Down

DENTSPLY SIRONA Stock (NASDAQ: XRAY) Weekend Update: Analysts Hold a “Reduce” View as Year-End Trading Winds Down

Dentsply Sirona (NASDAQ: XRAY) closed Friday at $11.52, up 2.7%, with about 5.5 million shares traded. Analysts maintain a cautious stance, with a consensus “Reduce” rating and an average target price of $15.15. The company’s $0.16 quarterly dividend goes to shareholders of record as of Dec. 26, with payout set for Jan. 9. CEO Daniel Scavilla has outlined a turnaround plan amid ongoing sales pressures.
28 December 2025
Dentsply Sirona (XRAY) Stock Weekend Update: Dividend, Turnaround Plan, Analyst Targets—and What to Watch When Nasdaq Reopens

Dentsply Sirona (XRAY) Stock Weekend Update: Dividend, Turnaround Plan, Analyst Targets—and What to Watch When Nasdaq Reopens

Dentsply Sirona shares last traded near $11.50, close to the lower end of their 52-week range, with U.S. markets closed early Saturday. The company reported Q3 net sales of $904 million, down 5%, and a GAAP net loss per share of $2.14 after a $263 million impairment. U.S. net sales fell 22% year over year. Management issued a “Return-to-Growth” plan and cut its 2025 outlook.
Go toTop